Cerebral Infarctions Not Yet Recruiting Phase 3 Trials for Tocilizumab (DB06273)

Also known as: Infarction Cerebral / Cerebral Infarct / Cerebral Infarction / Cerebral infarction, unspecified / Cerebral infarction (disorder) / Infarct cerebral / Occlusion of cerebral arteries / Occlusion of cerebral artery (disorder) / Cerebral artery occlusion, unspecified / Cerebral artery occlusion

DBCOND0047013 (Cerebral Infarctions)Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06447701Interleukin-6 Receptor Inhibition for Symptomatic Intracranial AtherosclerosisTreatment